Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

Recent & Breaking News (TSXV:VM)

Voyageur Minerals' Joint Venture Company, ImagingX Pharmaceuticals, Submits Third Barium Contrast Product to Health Canada for Registration

GlobeNewswire November 5, 2019

Voyageur Minerals Announces Mailing of Materials for the Annual and Special Meeting of Shareholders to be held November 12th, 2019 and a New Private Placement Financing

GlobeNewswire October 10, 2019

Voyageur Minerals Ltd Joint Venture Company, ImagingX Pharmaceuticals, Submits Second Barium Contrast Product to Health Canada for Registration

GlobeNewswire October 4, 2019

Voyageur Announces the Closing of Private Placements

GlobeNewswire September 26, 2019

Voyageur Minerals Board of Director Changes

GlobeNewswire September 12, 2019

Voyageur Minerals Appoints Pharmaceutical Expert to the Board of Directors

GlobeNewswire August 12, 2019

Voyageur Minerals' Joint Venture Company ImagingX Pharmaceuticals, Submits its First of Three Barium Contrast Products to Health Canada for Registration

GlobeNewswire August 8, 2019

Voyageur Minerals Announces Director Changes

GlobeNewswire August 7, 2019

Voyageur Closes First Tranche of Non-Brokered Private Placement

GlobeNewswire July 29, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire July 11, 2019

Voyageur Minerals Announces Management Change with New CEO and Director Appointments

GlobeNewswire July 4, 2019

Voyageur Announces the Closing of a $240,651.52 Private Placement

GlobeNewswire May 8, 2019

Voyageur Announces Financing of $400,000

GlobeNewswire April 26, 2019

Voyageur Progress Update

GlobeNewswire March 6, 2019

IIROC Trading Resumption - VM

Canada NewsWire February 8, 2019

Voyageur Minerals Begins Preliminary Feasibility –Clarification of Feb 5, 2018 press release

GlobeNewswire February 8, 2019

IIROC Trading Halt - VM

Canada NewsWire February 6, 2019

Voyageur Minerals Begins Preliminary Feasibility

GlobeNewswire February 6, 2019

Voyageur Minerals Submits Its Bulk Sample Permit Application for 10,000 Tonnes at Its Barite Property

GlobeNewswire January 21, 2019

ImagingX Pharmaceuticals Inc. formed by Voyageur Minerals and Chief Medical

GlobeNewswire January 9, 2019